Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Better Buy: Bitcoin vs. Ethereum


With Bitcoin (CRYPTO: BTC) down 47% from its all-time high of $126,000 just a few months ago, it's perhaps no surprise that crypto investors are starting to look elsewhere for opportunities.

For some investors, it means hunting for undervalued cryptocurrencies with the potential to outperform Bitcoin this year. One of those beaten-down cryptos is Ethereum (CRYPTO: ETH), which has historically played second fiddle to Bitcoin. But is that still the case in 2026?

The high-profile example that has investors buzzing is the recent decision by Harvard's $50 billion endowment fund to trim its exposure to Bitcoin and replace it with a brand-new position in Ethereum.

Continue reading


Source Fool.com

Harvard Bioscience Aktie

0,48 €
0,00 %
Unverändert zu gestern notiert heute die Harvard Bioscience Aktie.

Like: 0
ETH
Teilen

Kommentare